CNBX Pharmaceuticals | 10-Q: Quarterly report
CNBX Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
CNBX Pharmaceuticals | 8-K: Current report
CNBX Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-3i, LP(9.9%),3i Management LLC(9.9%), etc.
CNBX Pharmaceuticals | 10-Q: Quarterly report
CNBX Pharmaceuticals: FY2023 Annual Report
CNBX Pharmaceuticals | 10-Q: Q3 2023 Earnings Report
CNBX Pharmaceuticals | 10-Q: Q2 2023 Earnings Report
CNBX Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-3i, LP(9.98%),3i Management LLC(9.98%), etc.
CNBX Pharmaceuticals | 8-K: Current report
CNBX Pharmaceuticals | 10-Q: Q1 2023 Earnings Report
CNBX Pharmaceuticals | 8-K: Current report
CNBX Pharmaceuticals | RW: Registration Withdrawal Request
CNBX Pharmaceuticals: FY2022 Annual Report
10-K | CNBX Pharmaceuticals Inc. (0001343009) (Filer)
CNBX Pharmaceuticals | 8-K: Current report
CNBX Pharmaceuticals | 10-Q: Q3 2022 Earnings Report
CNBX Pharmaceuticals | 8-K: Current report
CNBX Pharmaceuticals | 10-Q: Q2 2022 Earnings Report
CNBX Pharmaceuticals | 8-K: Current report
CANNABICS PHARMACEUTICALS INC | 8-K: Current report
No Data